Bromfenac BID Plus Prednisolone Acetate BID Versus Bromfenac BID Plus Prednisolone QID for the Prevention of Cystoid Macular Edema and Retinal Thickening

Retinal Thickening Clinical Trial

Status Completed

Clinical Trial Summary

The objective of this study is to determine if twice-daily dosing of prednisolone (Pred Forte) is as effective as four-times-daily dosing of prednisolone for the prevention of retinal thickening and cystoid macular edema (CME) when either regimen is used concomitantly with twice-daily bromfenac.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00469781
Study type	Interventional
Source	Center For Excellence In Eye Care
Contact
Status	Completed
Phase	Phase 4
Start date	May 2007
Completion date	September 2008

View Details

See also
	Status	Clinical Trial	Phase
	Completed	`NCT04794634` - Relationship Between Alzheimer Disease and Diminution of the Three Macular Nervous Retinal Layers	N/A
	Enrolling by invitation	`NCT04285177` - Choroidal and Retinal Thickness Following Strabismus Surgery